Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.54.0625
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated With Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Organ Tolerance Following Cadaveric Liver Transplantation for Chronic Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
2002English

Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Encephalomyelitis Mimicking Multiple Sclerosis Associated With Chronic Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation

Internal Medicine
Internal MedicineMedicine
2009English

Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation

PLoS ONE
Multidisciplinary
2014English

Bone Marrow Transplantation: Graft Versus Host Disease and Oral Changes

Revista Odonto Ciencia
Dentistry
2012English

A Phase I/2 Study of Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis After Allogeneic Transplantation (alloHCT).

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy